Reuters logo
BRIEF-Medigene says 9M immunotherapy revenue 3.4 mln eur
November 9, 2017 / 6:41 AM / a month ago

BRIEF-Medigene says 9M immunotherapy revenue 3.4 mln eur

Nov 9 (Reuters) - Medigene

* Says confirms its financial guidance for 2017

* Says 9M revenue from core business immunotherapies (bluebird bio partnership) of eur 3.435 million

* Says 9M total revenue eur 7.176 million (9M 2016: eur 7.052 million)

* Says 9M EBITDA loss increased as planned to eur 10.143 million (9M 2016: eur 9.095 million) Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below